title: The Monostrut prosthetic valve. Predictors for valve-related events during an eight years' experience.
abstract: All postoperative complications, including transient ischaemic attacks (TIA) and cerebrovascular accidents (CVA) of 259 patients, in whom a total of 301 Monostrut tilting-disc valves were implanted between January 1985 and December 1991 were evaluated retrospectively. The follow-up was maximally 8 years, with a mean of 3.5 years, and totaled 914 patient-years. In this study we found no mechanical deterioration of the Monostrut valve and demonstrated the elimination of valve thrombosis in patients receiving adequate anticoagulation. The actuarial probability of being free of thrombo-embolism was 94.7% +/- 1.7% and free of anticoagulant related hemorrhage 95.4% +/- 1.5% at 8-years. In comparison with earlier reports by others, our findings show a lower ratio of thromboembolic and hemorrhagic events. We demonstrated a correlation (p < 0.05) between thrombo-embolic and hemorrhagic complications. In addition, a lower incidence of CVA's (0.22 per 100 patient-years), but a higher incidence of TIA's (0.66 per 100 patient-years) in comparison with the general Dutch population was found. At eight years follow-up, all patients were in Class I or II of the New York Heart Association Classification. Although the overall valve related event-free survival at eight years was only 47.9%, 93.5% of the patient were satisfied with their operative result. Predictive factors for late mortality were the occurrence of paravalvular leakage (p < 0.01), the age of the patient at the time of operation (p < 0.01) and the number of diseases coronary arteries (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Cardio-Thoracic Surgery, Catharina Hospital, Eindhoven, The Netherlands.
authors.forename: A K
authors.initials: AK
authors.lastname: Liem
authors.forename: E
authors.initials: E
authors.lastname: Berreklouw
authors.forename: B H
authors.initials: BH
authors.lastname: Van Straten
authors.forename: Y A
authors.initials: YA
authors.lastname: Mashhour
authors.forename: G
authors.initials: G
authors.lastname: Tavilla
authors.forename: I
authors.initials: I
authors.lastname: Ozdemir
authors.forename: H
authors.initials: H
authors.lastname: Bavinck
authors.forename: J P
authors.initials: JP
authors.lastname: Schönberger
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001021:Aortic Valve; D002423:Cause of Death; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects / Q000401:mortality / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve; D009426:Netherlands / Q000453:epidemiology; D011183:Postoperative Complications / Q000453:epidemiology / Q000401:mortality; D011379:Prognosis; D011474:Prosthesis Design / Q000706:statistics & numerical data; D011475:Prosthesis Failure; D012086:Reoperation / Q000706:statistics & numerical data